Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101519384A details a one-step synthesis of chiral oxazolines. Offers high enantioselectivity for asymmetric catalysis and scalable manufacturing solutions.
Patent CN108912055B details a catalytic asymmetric dihydroxylation route for antiviral intermediates, offering cost-effective and scalable manufacturing solutions for global supply chains.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN116554056A reveals a novel one-pot base-catalyzed synthesis for high-purity cyclohexane intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Patent CN102633802B details a scalable 3-step route for 2-chloro-7H-pyrrolo[2,3-d]pyrimidine, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN101319236A details a green biocatalytic method for chiral alcohols using ionic liquids. Achieve high purity and cost reduction in pharma intermediate manufacturing with scalable processes.
Patent CN116554056A reveals a novel one-pot base-catalyzed route for cyclohexane derivatives, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Patent CN113429349B details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective manufacturing.
Advanced manufacturing route for Vilazodone intermediates utilizing microwave cyanation and efficient piperazine cyclization, offering high purity and scalable production for pharmaceutical supply chains.
Patent CN101602713B reveals a novel alkaline hydrolysis route for 2-chloronicotinic acid, offering 93% yield and significant cost reduction in agrochemical intermediate manufacturing.
Patent CN106748605A details a green TBAB-Oxone method for o-dicarbonyl compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116356354A reveals a green electrochemical route for 2-aryl-3-sulfonyl compounds, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN101823941A details a catalyst-free, water-based chlorination process for PCMX, offering significant cost reduction and environmental compliance for disinfectant manufacturing.
Patent CN114853838B reveals a low-cost, high-yield preparation method for abiraterone acetate, offering significant supply chain advantages for pharmaceutical manufacturers.
Patent CN111116441B details a recyclable sulfur ylide method for epoxide synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Novel 3-step route for Salan ligands via CN102786466A. High yield, mild conditions, scalable process for asymmetric catalysis applications.
Patent CN108164398A details a novel reduction method eliminating column chromatography. This breakthrough ensures scalable production and substantial cost reduction for global supply chains.
Advanced catalytic route for Pentafluorobenzonitrile ensures high purity and supply stability for global quinolone manufacturing chains efficiently.